Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment

IMPORTANCE: The prevalence of persistent diabetic macular edema (DME) after months of anti–vascular endothelial growth factor therapy and its effect on visual acuity are unknown. OBJECTIVE: To assess subsequent outcomes of eyes with DME persisting for 24 weeks after initiating treatment with 0.5 mg...

Full description

Saved in:
Bibliographic Details
Published in:JAMA Ophthalmol
Main Authors: Bressler, Susan B., Ayala, Allison R., Bressler, Neil M., Melia, Michele, Qin, Haijing, Ferris, Frederick L., Flaxel, Christina J., Friedman, Scott M., Glassman, Adam R., Jampol, Lee M., Rauser, Michael E.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4786449/
https://ncbi.nlm.nih.gov/pubmed/26746868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2015.5346
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items